AU2003278955A1 - METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS - Google Patents

METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS

Info

Publication number
AU2003278955A1
AU2003278955A1 AU2003278955A AU2003278955A AU2003278955A1 AU 2003278955 A1 AU2003278955 A1 AU 2003278955A1 AU 2003278955 A AU2003278955 A AU 2003278955A AU 2003278955 A AU2003278955 A AU 2003278955A AU 2003278955 A1 AU2003278955 A1 AU 2003278955A1
Authority
AU
Australia
Prior art keywords
inhibitors
rheumatoid arthritis
treating rheumatoid
treating
arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278955A
Inventor
Christopher Cyril Chadwick
Douglas Carl Harnish
James Carl Keith Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of AU2003278955A1 publication Critical patent/AU2003278955A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003278955A 2003-09-24 2003-09-24 METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS Abandoned AU2003278955A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/030339 WO2005039583A1 (en) 2003-09-24 2003-09-24 METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS

Publications (1)

Publication Number Publication Date
AU2003278955A1 true AU2003278955A1 (en) 2005-05-11

Family

ID=34519489

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278955A Abandoned AU2003278955A1 (en) 2003-09-24 2003-09-24 METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS

Country Status (2)

Country Link
AU (1) AU2003278955A1 (en)
WO (1) WO2005039583A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050004164A1 (en) * 2003-04-30 2005-01-06 Caggiano Thomas J. 2-Cyanopropanoic acid amide and ester derivatives and methods of their use
CN1968932A (en) * 2004-06-18 2007-05-23 惠氏公司 Processes for preparing 6-alkyl-5-arylsulfonyl-dihydrophenanthridines
WO2009004104A1 (en) * 2007-06-29 2009-01-08 Fundación Marqués De Valdecilla Use of a polymorphism in the card8 gen for prognosis of rheumatoid arthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
DE10039199A1 (en) * 2000-08-10 2002-02-21 Schering Ag Combination preparations from an ERß selective estrogen and a SERM or antiestrogen
US6884814B2 (en) * 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents

Also Published As

Publication number Publication date
WO2005039583A1 (en) 2005-05-06

Similar Documents

Publication Publication Date Title
EP1635822A4 (en) Methods and compositions for treating rheumatoid arthritis
AU2003258855A1 (en) Method for the reduction of acrylamide formation
AU2003236304A1 (en) Method of treating substrate
EP1578695B8 (en) Method for removal of biofilm
AU2003304722A1 (en) Method for treating waste-activated sludge using elecroporation
IL166600A0 (en) Method of treating osteoarthritis
AU2003277596A1 (en) Method of deuterization
AU4256901A (en) Method of screening for inhibitors of osteopontin
AU2003254942A1 (en) Treating apparatus and method of treating
AU2003231516A1 (en) Method of treating substrate
EP1595850A4 (en) Method of desalting
AU2003288901A1 (en) Treatment of rheumatoid arthritis by inhibition of pde4
AU2003290890A1 (en) Method of treating an elastomeric article
AU2003260909A1 (en) Method of enhancing multimedia
AU2003278955A1 (en) METHOD OF TREATING RHEUMATOID ARTHRITIS USING NF-kB INHIBITORS
AUPS201002A0 (en) Method of treating shellfish
AU2003221005A1 (en) Method of wastewater treatment
AU2003248584A1 (en) Method of treating osteoarthritis
AU2003288762A1 (en) Method and apparatus of hemorheometer
AU2003272676A1 (en) METHODS OF TREATING ATHEROSCLEROSIS USING NF-kB INHIBITORS
AU2003237199A1 (en) Method of treating multiple sclerosis
AU2002951913A0 (en) Method of treatment
AU2003221510A1 (en) Method of prefetching data/instructions
AU2003304113A1 (en) Time delay apparatus and method of using same
AU2003255885A1 (en) Method of encoding lines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase